ResQPOD impedance threshold device for cardiac arrest

Purins A, Mundy L, Hiller JE
Record ID 32012000231
Authors' recommendations: The ResQPOD has shown some promise in early trials improving surrogate markers of survival. As so few patients in either normal or ResQPOD treated groups survive to hospital discharge, the studies reviewed here lack the power to elucidate any long term survival changes. Due to the lack of evidence supporting any long term benefits of the ResQPOD, HealthPACT has recommended that further assessment of this technology is no longer warranted.
Project Status: Completed
Year Published: 2008
URL for published report: Not Available
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Cardiopulmonary Resuscitation
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
Contact Email:
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.